Diabetes & Endocrinologyanti-ZSCAN1 antibodyautonomic dysregulation
Unraveling ROHHAD-NET Syndrome: Clinical Insights and the Role of Anti-ZSCAN1 Antibodies in Diagnosis and Management
By MedXY|Jul 19, 2026
This nationwide Japanese study elucidates early clinical features of ROHHAD-NET syndrome and highlights anti-ZSCAN1 antibody titers as potential biomarkers linked to neural crest tumors and treatment response.